Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Absolute risk of atypical fracture with bisphosphonates is low, data suggest

By News team

Bisphosphonates are associated with a small absolute risk of atypical fracture, according to findings from a large, population-based study funded by the Swedish Research Council.

Researchers used the National Swedish Patient Register to establish that 12,777 women aged 55 and older had sustained a fracture of the femur in 2008. They reviewed X-rays for 1,234 women who had a subtrochanteric or shaft fracture and identified 59 patients who had atypical fractures. These were compared with 263 control patients who had ordinary shaft fractures.

The study, published in the New England Journal of Medicine (2011;364:1728), reported a high prevalence of current bisphosphonate use among patients with atypical fractures — 78 per cent compared with 10 per cent of the controls.

The age-adjusted relative risk of atypical fracture was 47.3 (95 percent confidence interval, 25.6 to 87.3). However, the increase in absolute risk was just 5 cases per 10,000 patient years (95 percent confidence interval, 4–7), the authors of the study note.

The risk appeared to be unrelated to the use of systemic glucocorticoids and other drugs with effects on bone and was independent of coexisting conditions and age. The duration of bisphosphonate use influenced the risk but after drug withdrawal the risk diminished rapidly, falling by 70 per cent per year.

The authors say: “With a correct indication, the benefits of fracture prevention with bisphosphonate use will greatly outweigh the risk of atypical femoral fracture.”

Citation: The Pharmaceutical Journal URI: 11075083

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.